Gadolinium has revolutionized our ability to visualize the internal structure of the human body with greater detail and better contrast. The use of gadolinium as a contrast agent has opened the door to earlier detection and more accurate diagnosis of various medical conditions, such as tumors, inflammation, vascular disorders, and more. One of the main properties of gadolinium is its magnetic properties. It has a high magnetic moment, which produces intense signals in MRI. The literature search process was carried out on various databases (PubMed, Web of Sciences, EMBASE, Cochrane Libraries, and Google Scholar) regarding the potential of gadolinium as a contrast agent in MRI applications. This study follows the preferred reporting items for systematic reviews and meta-analysis (PRISMA) recommendations. Gadolinium is an invaluable contrast agent in MRI (Magnetic Resonance Imaging) that has various potential and important benefits in the world of medical radiology. Gadolinium's unique magnetic properties allow for increased contrast in MRI images, making it easier to identify and better understand structures in the body. Gadolinium is very effective in detecting lesions, pathological changes, such as tumors, swelling, inflammation, and vascular problems. This allows early and accurate diagnosis, appropriate treatment planning, as well as monitoring disease progression. There are various types of gadolinium contrast agents that can be tailored to the needs of certain MRI examinations, such as gadopentetate dimeglumine, gadobutrol, gadodiamide, and others. Gadolinium is generally considered a safe and relatively non-toxic contrast agent. However, it is necessary to pay attention to very rare allergic reactions and the risk of accumulation in patients with impaired kidney function.